AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Pubmed Ncbi Nlm Nih

Published November 13, 2026 · Updated November 14, 2026

Researchers' Experiences with IRB Oversight of Psychedelic Research - PubMed

Read the full story at Pubmed Ncbi Nlm Nih

psychedelic drugs. We interviewed 20 US researchers who had been a principal investigator on at least one research protocol involving psychedelics.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelics